In addition, in the study of tumor drug resistance, the overexpression of USP39 can increase the resistance of colorectal and ovarian cancer cells to chemotherapeutic drugs; this resistance can be reversed by knocking down USP39 expression. Here, USP39 is linked to neoplasm.